Fu Wen-bin, Fan Li, Zhu Xao-ping, He Qing, Wang Ling, Zhuang Li-xing, Liu Yan-sheng, Tang Chun-zhi, Li Ying-wen, Meng Chang-rong, Zhang Hong-lai, Yan Jie
Acupuncture Department of Guangdong Provincial Hospital of TCM, Guangzhou 510120, China.
Zhongguo Zhen Jiu. 2008 Jan;28(1):3-6.
To observe the clinical therapeutic effect of acupuncture on depressive neurosis.
With a multi-center randomized controlled study, 440 cases were randomly divided into an acupuncture group, a prozac group, a non-acupoint needling group. In the acupuncture group, Hegu (LI 4) and Taichong (LR 3) were selected, and the Prozac group were treated with administration of 20 mg/d and the non-acupoint needling group were treated with needling the points deviating from the acupoints. The therapeutic effect was evaluated by HAMD score reduction rate, and Asberg's anti-depressant side-effect rating scale (SERS) and severe adverse reaction were used for safety evaluation, and the data were analyzed with ITT.
The total effective rate was 86. 4% in the acupuncture group, which was better than 59.1% in the non-acupoint needling group and 72.7% in the prozac group; HAMD score in the acupuncture group was similar to that in the Prozac group, which was better than that in the non-acupoint needling group; the SERS scores in the acupuncture group and the non-acupoint needling group were significantly lower than that in the Prozac group, with no severe side-effects found for acupuncture.
Acupuncture is an effective and safe therapy for depressive neurosis; therapeutic effect of acupuncture on depressive neurosis possibly is better than or similar to that of Prozac, but with less side-effects.
观察针刺治疗抑郁性神经症的临床疗效。
采用多中心随机对照研究,将440例患者随机分为针刺组、百忧解组、非经穴针刺组。针刺组选取合谷(LI 4)、太冲(LR 3),百忧解组给予20mg/d口服,非经穴针刺组针刺非经穴部位。以HAMD评分减分率评价疗效,采用Asberg抗抑郁副反应量表(SERS)及严重不良反应进行安全性评价,采用意向性分析(ITT)处理数据。
针刺组总有效率为86.4%,优于非经穴针刺组的59.1%及百忧解组的72.7%;针刺组HAMD评分与百忧解组相近,优于非经穴针刺组;针刺组和非经穴针刺组SERS评分均显著低于百忧解组,针刺未发现严重不良反应。
针刺是治疗抑郁性神经症的一种有效、安全的疗法;针刺治疗抑郁性神经症的疗效可能优于或类似于百忧解,但副作用较少。